#ESCCongress 🇳🇱 2023 Dr Luigi Biasco interviews 🎤 Troels Højsgaard Jørgensen about the outcomes of the NOTION (Nordic Aortic Valve Intervention) 10 year trial. What can you learn about valve durability and life expectancy in patients above 70 years of age? Watch the video!

A great coverage for #ESCCongress.thanks all for your work and dedication PCRonline 🫀 A.Nazmi Calik Elad Asher Dr Luigi Biasco Daniele Giacoppo Dejan Milasinovic MIЯVΛƬ #IC Nicola Ryan Luis Ortega Paz Panos Xaplanteris Alessandro Sticchi Professor Vijay Kunadian

1 year already when we lost our friend and colleague Michele Pighi. A beautiful person and an excellent cardiologist. PCRonline 🫀 you will be always missed

Getting ready for #TCT2023? So are we! MIЯVΛƬ #IC Elad Asher Dr Luigi Biasco Aaysha Cader A.Nazmi Calik Dejan Milasinovic Luis Ortega Paz Alessandro Sticchi and Panos Xaplanteris will be providing you with the international perspective via condensed take-home messages 📝🎤 covering major late-breaking

#TCT2023 TRILUMINATE Dr Luigi Biasco interviews 🎤 Suzanne Arnold about the results 📊 of this trial that studied quality of life after transcatheter tricuspid-valve repair vs. medical therapy in severe TR 📺 pcronline.com/News/Whats-new… #TreatTR #FixTR #cardiotwitter

Catch up on all the science from #TCT2023 Read or listen to discussion of the hot topics from PCRonline 🫀 companions. MIЯVΛƬ #IC Dr Luigi Biasco Aaysha Cader A.Nazmi Calik Dejan Milasinovic Luis Ortega Paz Alessandro Sticchi Panos Xaplanteris pcronline.com/tiny/url/696181

The mortality burden of untreated aortic stenosis In the run-up to #PCRLV, read this #EAPCI/PCR journal club review ✍️🏻 of this study based on extensive real-world data 📊which aimed to assess mortality rates across different untreated AS severities and AS treatment rates.

#PCRLV: How does survival between men and women undergoing mTEER differ? Dr Luigi Biasco presents findings from the MitraSwiss registry, showing females had a 3-fold lower rate of 30 day mortality, and a restoration of life expectancy at five years

New data suggest it is time for consideration of sex-specific thresholds for LVESDi in surgical decision making for patients with severe MR: bit.ly/41VEKQt #JACC #vhdMR #CardioX

#AI-derived risk score for mortality in secondary mitral regurgitation treated by #TEER: the EuroSMR risk score The study aim was to develop and validate a novel score for prediction of 1-year mortality and clinical outcomes through artificial intelligence (AI) application in

Change in Cardiology 4.0: in arrivo a Torino il congresso dedicato alla cardiologia quotidianopiemontese.it/2024/03/19/cha…

#ACC24: #ORBITA-COSMIC Aaysha Cader interviews 🎤 Rasha Al-Lamee and Michael Foley about this trial that showed that coronary sinus reducer relieved angina symptoms, but lacked evidence of increased blood flow to the heart. While beneficial for refractory angina patients, its

A Torino il congresso internazionale Change in Cardiology 4.0 ansa.it/piemonte/notiz…

#EuroPCR 2024 Major LBTs 🔥LANDMARK Early outcomes of a randomised non-inferiority trial comparing #TAVI devices. Results of this trial presented by P.W. Serruys, on Wednesday 15/05 at 08h30. Followed by a methodology insight by Davide Capodanno & impact in practice by Marty Leon

#EuroPCR 2024 Major LBT – LANDMARK Previous head-to-head comparisons of new THVs with established devices confirmed no class effect of clinical benefits after #TAVI with inferior safety & efficacy for some of them. Validation of MyVal non-inferiority to the most widely used

NOTION-2 did not demonstrate the noninferiority of TAVI compared to surgery for the primary endpoint at 1 year. Due to fewer events than anticipated in the surgery group, the trial lost statistical power, resulting in widened confidence intervals that crossed both the

Besides the education & science, #EuroPCR is also the opportunity to catch-up on activities that take place all year long. Thank you 🙏 to the #EAPCI/PCR Journal Club team, led by Nicola Ryan for all their hard work in reviewing ✍️ major scientific papers for

Live from the #ESCCongress in London 🇬🇧 MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary MR treated by #TEER Read this analysis ✍️ by Jonathan Curio pcronline.com/News/Whats-new… #TMVR #AI